OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

Recombinant antibody production employs Chinese hamster ovary (CHO) cells due to their adaptability in expressing complex proteins. Improving these processes involves adjusting various parameters, including cell line development, media composition, and bioreactor settings. A key goal is to maximize antibody titer while reducing production expenses